Tag: CYP2D6
-
Improving Atomoxetine Dosage for the Treatment of Attention Deficit Hyperactivity Disorder in Children: The Need for Personalized Pharmacovigilance
In recent years, Attention Deficit Hyperactivity Disorder (ADHD) has become one of the most common neurodevelopmental disorders among children, highlighting the urgent need for effective and tailored therapeutic strategies. In this context, the substance “Atomoxetine” emerges as a non-stimulant medication, recognized in various clinical guidelines as an important alternative to stimulant treatments. Although the effectiveness…